Agenus | AGEN - 市值



金融业
股票价格
USD
资产
USD 172.69M
现金及等价物
USD 18.74M
销售成本
USD 642K
流动资产
USD 78.81M
流动负债
USD 231.82M
债务
USD 35.54M
股息收益率
0
EBIT
USD 15.05M
EBITDA
USD -10.11M
员工
389
EPS每股收益
USD 1.02
股本和储备
USD -199.08M
销售毛利
USD 33.74M
债务利息支出
USD 14.67M
贷款资金
USD 153.99M
市值
USD 3.37B
净收入
USD 39.17M
营业费用
USD -199.08M
营业利润
USD 15.05M
普通股股本
USD 38.52M
PE价格收益
17.82
税前利润
USD 39.21M
销售收入
USD 33.7M
销售和管理费用
USD 6.21M
贸易债权人
USD 58.98M
应收帐款人
USD 22.34M


市值 更改 日
AbbVie USD 444.6B 59.91B 2026-06
Agenus USD 128M 21M 2026-03
Amgen USD 195.44B 5.55B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Celldex Therapeutics USD 2.92B 809M 2026-06
CSL USD 55.89B 20.42B 2025-12
Eli Lilly USD 1.13T 260.54B 2026-06
Gilead Sciences USD 156.86B 16.13B 2026-06
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Glaxosmithkline GBP 109.29B 9.36B 2026-03
Incyte USD 22.65B 3.92B 2026-06
J&J USD 611.36B 32.21B 2026-06
Jiangsu Hengrui CNY 344.89B 22.02B 2026-06
Karyopharm Therapeutics USD 126M 9M 2026-03
MacroGenics USD 184M 82M 2026-03
Merck EUR 18.98B 27.8B 2026-06
Merck USD 317.37B 20.27B 2026-06
Northwest Biotherapeutics USD 332M 24M 2026-03
Novartis USD 240.59B 67.17B 2026-06
Novavax USD 1.09B 316M 2025-12
Pfizer USD 138.44B 15.37B 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Veracyte USD 4.69B 2.12B 2026-06